Trial Details
RECRUITINGBasic Information
| Clinical ID | c1035 |
|---|---|
| Identifier | NCT05660746 |
| Trial Title | Precise Infliximab Exposure and Pharmacodynamic Control |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | DEVICE: RoadMAB|DRUG: Infliximab |
Participant Information
| Sponsor | Children's Hospital Medical Center, Cincinnati |
|---|---|
| City | Los Angeles |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | CHILD, ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE2|PHASE3 |
Time Information
| Start Date | 2023-07-01 |
|---|---|
| Primary Completion Date | 2027-03-31 |
| Completion Date | 2027-03-31 |